These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 2839585)
1. [Studies on estrogen replacement therapy with conjugated estrogens by histological evaluation of the endometrium of 205 women]. Aoki T Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jun; 40(6):736-40. PubMed ID: 2839585 [TBL] [Abstract][Full Text] [Related]
2. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding. Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025 [TBL] [Abstract][Full Text] [Related]
3. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin. Xing S; Wu Y; Liu J; Xu R; Zhang Z; Wang Y Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis]. Wu Y; Liu J; Xing S; Xu R; Zhang Z; Wang Y Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):267-70. PubMed ID: 12133397 [TBL] [Abstract][Full Text] [Related]
5. Transdermal progesterone cream as an alternative progestin in hormone therapy. Leonetti HB; Landes J; Steinberg D; Anasti JN Altern Ther Health Med; 2005; 11(6):36-8. PubMed ID: 16320858 [TBL] [Abstract][Full Text] [Related]
6. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women. Magos AL; Brincat M; Studd JW; Wardle P; Schlesinger P; O'Dowd T Obstet Gynecol; 1985 Apr; 65(4):496-9. PubMed ID: 2984616 [TBL] [Abstract][Full Text] [Related]
7. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201 [TBL] [Abstract][Full Text] [Related]
8. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy. Luciano AA; Turksoy RN; Carleo J; Hendrix JW Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082 [TBL] [Abstract][Full Text] [Related]
9. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525 [TBL] [Abstract][Full Text] [Related]
10. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium. Gelfand MM; Ferenczy A Obstet Gynecol; 1989 Sep; 74(3 Pt 1):398-402. PubMed ID: 2548135 [TBL] [Abstract][Full Text] [Related]
11. [Medroxyprogesterone acetate in adenomatous hyperplasia of the uterine endometrium. Clinical and morphologic studies on the duration and dosage of gestagen therapy]. Dallenbach-Hellweg G; Czernobilsky B; Allemann J Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):601-8. PubMed ID: 2945751 [TBL] [Abstract][Full Text] [Related]
12. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium. Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899 [TBL] [Abstract][Full Text] [Related]
13. The role of hormone replacement therapy in endometrial polyp formation. Oguz S; Sargin A; Kelekci S; Aytan H; Tapisiz OL; Mollamahmutoglu L Maturitas; 2005 Mar; 50(3):231-6. PubMed ID: 15734604 [TBL] [Abstract][Full Text] [Related]
14. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Archer DF; Pickar JH; Bottiglioni F Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926 [TBL] [Abstract][Full Text] [Related]
15. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT. Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052 [TBL] [Abstract][Full Text] [Related]
17. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. Odmark IS; Jonsson B; Bäckström T Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178 [TBL] [Abstract][Full Text] [Related]
18. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women. Leather AT; Savvas M; Studd JW Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699 [TBL] [Abstract][Full Text] [Related]